Developer docs
API playgroundTry for free, no card

Search company profiles

Lungscreen

Full company profile

uuid004tkhe

Namestring
Lungscreen
Legal namestring
Lung Screen Australia Pty Ltd
Websiteurl
lungscreen.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Lungscreen (legal entity Lung Screen Australia Pty Ltd) is a privately held Australian lung screening services and imaging technology provider founded in 2016 and headquartered in Buderim, Queensland. The company operates across three service lines: occupational lung disease screening for Queensland coal, mineral mine, and quarry workers (where it is the sole government-appointed provider of dual-read ILO screening under the Coal Mine Workers' Health Scheme), participation in the federal National Lung Cancer Screening Program as a reporting platform provider, and a Virtual Lung Nodule Clinic offering nationwide incidental nodule surveillance.

The technology stack centres on two proprietary assets: Radar, a bespoke cloud-based radiologist reporting platform with standardised templates, double-reading workflows, and adjudication; and a Vendor Neutral Archive hosted on Australian Microsoft Azure infrastructure. AI capabilities augment CT and chest X-ray interpretation through nodule detection and characterisation, incidental finding flagging, and AI-assisted structured report generation. The platform is integrated with Telstra Health for automated submission of synoptic reports to the national lung cancer screening registry, and the radiologist network is benchmarked against the University of Illinois at Chicago.

Lungscreen makes money primarily through fee-per-assessment occupational screening billed to employers, workers, and radiology clinics under published schedules, supplemented by recurring service contracts with radiology provider partners (Lumus Imaging, PRP Imaging, Carlisle Health, Radiology SA, Imaging Associates) who use Lungscreen as their NLCSP reporting layer, and by professional services revenue from the Virtual Lung Nodule Clinic. The company is privately held, bootstrapped, and led by Dr Siavash Es'haghi (Managing Director/CEO) with approximately 10 employees including 10 subspecialist chest radiologists.

Short descriptiontext

Lungscreen is a Queensland-based lung screening services and imaging technology provider that delivers ILO-standard occupational screening, National Lung Cancer Screening Program reporting, and lung nodule management through its Radar platform and Azure-hosted Vendor Neutral Archive for radiology providers, employers, and government.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBuderim, Australia
HQ citystring
Buderim
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
lung screening services, occupational lung disease, lung cancer screening, diagnostic imaging reporting, lung nodule management
Industry4 codes
PRIMARYHLAKANAI
Lung Cancer Screening & Pulmonary Nodule Clinic
SECONDARYHLAKANAN
Occupational & Environmental Lung Disease Clinic
SECONDARYHLAKAFAL
Thoracic (Lung) Oncology
SECONDARYHLAFAKAJ
Pulmonary Function & Respiratory Diagnostic Centers (PFT/Spirometry)
NAICS code1 code
  • Diagnostic Imaging Centers621512
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Lung Screening Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Government-Commissioned Screening Services
TypeSubscription Recurring
Description

Lungscreen is the sole appointed provider by the Queensland Government to deliver dual-read ILO screening under the Coal Mine Workers' Health Scheme. Revenue is derived from legislated health assessments that coal and quarry mine workers are required to undergo at least every 5 years, before employment, and at retirement.

lungscreen.com
2Fee-for-Service Occupational Lung Disease Screening
TypeOne Time License
Description

Chest X-ray ILO reporting, spirometry coordination, and dual-reading services are billed per worker per assessment. Pricing schedules are publicly available (Schedule of Fees). Services cover coal mine workers, mineral mine, and quarry workers under Queensland regulations.

lungscreen.com
3National Lung Cancer Screening Program (NLCSP) Services
TypeSubscription Recurring
Description

Lung cancer screening services including LDCT scans, AI-driven reporting, synoptic report generation, and Telstra Health registry integration, provided to radiology providers and GP practices participating in the national program.

lungscreen.com
4Lung Nodule Management Services
TypeProfessional Services
Description

Virtual Lung Nodule Clinic providing specialist clinical review, coordinated follow-up, and surveillance services for incidental pulmonary nodules across Australia, supporting both patients and referring clinicians.

lungscreen.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Occupational Lung Disease Screening - Per Worker Assessment
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Fee-per-assessment pricing model for chest X-ray ILO reporting, spirometry coordination, and dual-reading. Specific amounts are available in the downloadable Schedule of Fees documents (occupational-schedule-of-fees-as-of-1st-march-2025.pdf).

lungscreen.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1Radar
Description

Bespoke cloud-based reporting software for radiologists, designed to streamline and standardise the reporting process for occupational health.

lungscreen.com
+1 more record
Core offering1 text field

Lungscreen delivers lung screening and diagnostic imaging services covering occupational lung disease screening for mine and quarry workers, low-dose CT lung cancer screening under the National Lung Cancer Screening Program (NLCSP), and virtual lung nodule management. The company operates a proprietary cloud-based reporting platform (Radar), a Vendor Neutral Archive (VNA) on Australian-hosted Microsoft Azure, and AI-driven image analysis, with dual-read ILO-standard reporting performed by NIOSH-accredited B-Reader radiologists.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Lungscreen is the only organisation appointed by the Queensland Government to deliver dual-read ILO screening under the Coal Mine Workers' Health Scheme
+3 more records
Product overview1 text field

Lungscreen is a lung screening technology platform consisting of three core service areas: Occupational Lung Disease Screening (covering Coal Mine Workers' Health Scheme and Mining & Quarrying programs), Lung Cancer Screening (National Lung Cancer Screening Program), and Lung Nodule Management. The platform is powered by two proprietary technology systems: Radar, a cloud-based reporting software for radiologists with double-reporting and adjudication workflows, and a Vendor Neutral Archive (VNA) for secure image storage. AI capabilities augment nodule detection, characterisation, and report generation across all screening services.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1University of Illinois at Chicago (UIC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Lungscreen participates in an international auditing program with UIC, a recognised authority in ILO reporting. This benchmarking partnership ensures Lungscreen's processes and radiologist reporting meet global best practices and maintains high standards of diagnostic accuracy in lung health.

lungscreen.com
Strategic tierCoreTypeTechnology or Integration
Description

Lungscreen's reporting platform is integrated with Telstra Health for the National Lung Cancer Screening Program, enabling automated submission of structured, synoptic reports with detailed nodule data, Lung-RADS scores, patient demographics, and smoking history to the national registry.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Lumus Imaging is a radiology provider partner that uses Lungscreen's AI-enabled lung cancer screening platform and compliant synoptic reporting infrastructure. Their clinics perform CT scans and leverage Lungscreen's integrated reporting platform.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

PRP Imaging is a radiology provider partner using Lungscreen's reporting platform and nodule management services for lung screening and occupational lung disease assessments.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Carlisle Health is a radiology provider partner for lung cancer screening and occupational lung disease services using Lungscreen's platform.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Radiology SA is a radiology provider partner using Lungscreen's platform for lung screening services.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Imaging Associates is a radiology provider partner for lung cancer screening program services using Lungscreen's platform.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

RSHQ is a Queensland government body regulating mining safety. Lungscreen is the sole appointed provider of dual-read ILO screening services under the Coal Mine Workers' Health Scheme, a legislated program protecting respiratory health of workers in Queensland's coal mining industry.

9Microsoft Azure
Strategic tierCoreTypeTechnology or Integration
Description

Lungscreen's VNA is hosted on Microsoft Azure servers located in Australia. Azure is endorsed by the Australian Federal Government due to its security protocols, ensuring all patient data is secure in line with Australia's privacy policies.

lungscreen.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Australia's largest occupational health provider delivering pre-employment and periodic health assessments across industries including mining. Comparable to Lungscreen as an occupational screening provider to Queensland mining workers, with similar employer-led channels and health assessment workflow orientation.

TypeBroad incumbent
Description

ASX-listed Australian diagnostic imaging network providing radiology services across multiple states. Comparable to Lungscreen as a clinical imaging provider for lung cancer screening and adjacent diagnostic workflows, though diversified across all modalities rather than lung-specialised.

TypeEmerging player
Description

AI-driven lung cancer screening platform for pulmonary nodule management and Lung-RADS decision support. Comparable to Lungscreen's AI nodule detection and lung cancer screening capabilities, though Optellum is an AI software provider rather than a full-service screening operator.

TypeBroad incumbent
Description

Australia's largest radiology provider, operating hundreds of clinics across the country. Directly comparable to Lungscreen as a clinical imaging provider for lung cancer screening under NLCSP and adjacent occupational imaging, though it operates across all modalities rather than specialising in lung screening.

TypeDirect peer
Description

Australian radiology provider and named Lungscreen channel partner using its AI-enabled lung cancer screening platform. Operates many of the same chest X-ray and CT imaging clinics Lungscreen relies on for scanning delivery, making it both a partner and a potential in-house competitor for primary lung screening reporting.

TypeEmerging player
Description

US-based AI imaging company specialising in chest X-ray and CT interpretation, including ClearRead and LungPlot products. Direct technology peer to Lungscreen in AI-driven nodule detection and chest X-ray reporting augmentation.

TypeEmerging player
Description

Australian-headquartered comprehensive radiology AI platform covering chest X-ray and CT findings, including lung-related pathologies. Direct technology overlap with Lungscreen's AI imaging and report-generation stack, and is an Australian-based peer competing for similar radiology-provider AI deployments.

TypeBroad incumbent
Description

Korean-listed medical imaging AI company with FDA-cleared lung nodule detection and breast cancer AI products (post-Volpara acquisition). Comparable in lung cancer and imaging AI modality, and increasingly relevant as NLCSP and similar screening programs worldwide standardise AI-augmented reporting workflows.

TypeRegional player
Description

Major Queensland-headquartered diagnostic imaging provider operating across multiple modalities. Comparable to Lungscreen as a regional radiology network in Queensland with potential overlap in lung CT, NLCSP, and occupational chest imaging volumes.

TypeBroad incumbent
Description

Australian-headquartered occupational and remote health services provider with established mining and industrial health screening offerings. Comparable to Lungscreen's occupational lung disease screening segment for mining and industrial workforces, particularly in Queensland and regional Australia.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lungscreen

Lung Screening Serviceslungscreen.com

Lungscreen is a Queensland-based lung screening services and imaging technology provider that delivers ILO-standard occupational screening, National Lung Cancer Screening Program reporting, and lung nodule management through its Radar platform and Azure-hosted Vendor Neutral Archive for radiology providers, employers, and government.

What Lungscreen does

Lungscreen (legal entity Lung Screen Australia Pty Ltd) is a privately held Australian lung screening services and imaging technology provider founded in 2016 and headquartered in Buderim, Queensland. The company operates across three service lines: occupational lung disease screening for Queensland coal, mineral mine, and quarry workers (where it is the sole government-appointed provider of dual-read ILO screening under the Coal Mine Workers' Health Scheme), participation in the federal National Lung Cancer Screening Program as a reporting platform provider, and a Virtual Lung Nodule Clinic offering nationwide incidental nodule surveillance.

The technology stack centres on two proprietary assets: Radar, a bespoke cloud-based radiologist reporting platform with standardised templates, double-reading workflows, and adjudication; and a Vendor Neutral Archive hosted on Australian Microsoft Azure infrastructure. AI capabilities augment CT and chest X-ray interpretation through nodule detection and characterisation, incidental finding flagging, and AI-assisted structured report generation. The platform is integrated with Telstra Health for automated submission of synoptic reports to the national lung cancer screening registry, and the radiologist network is benchmarked against the University of Illinois at Chicago.

Lungscreen makes money primarily through fee-per-assessment occupational screening billed to employers, workers, and radiology clinics under published schedules, supplemented by recurring service contracts with radiology provider partners (Lumus Imaging, PRP Imaging, Carlisle Health, Radiology SA, Imaging Associates) who use Lungscreen as their NLCSP reporting layer, and by professional services revenue from the Virtual Lung Nodule Clinic. The company is privately held, bootstrapped, and led by Dr Siavash Es'haghi (Managing Director/CEO) with approximately 10 employees including 10 subspecialist chest radiologists.

Lungscreen firmographics

Firmographics
Name
Lungscreen
Legal name
Lung Screen Australia Pty Ltd
Website
https://lungscreen.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Lungscreen is a Queensland-based lung screening services and imaging technology provider that delivers ILO-standard occupational screening, National Lung Cancer Screening Program reporting, and lung nodule management through its Radar platform and Azure-hosted Vendor Neutral Archive for radiology providers, employers, and government.
Ownership category
akta.pro rank

Lungscreen industry classification

Industry
Product category
Lung Screening Services
NAICS
Diagnostic Imaging Centers (621512)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAKANAI
Lung Cancer Screening & Pulmonary Nodule Clinic
SECONDARYHLAKANAN
Occupational & Environmental Lung Disease Clinic
SECONDARYHLAKAFAL
Thoracic (Lung) Oncology
SECONDARYHLAFAKAJ
Pulmonary Function & Respiratory Diagnostic Centers (PFT/Spirometry)

Keywords

  • Lung screening services
  • Occupational lung disease
  • Lung cancer screening
  • Diagnostic imaging reporting
  • Lung nodule management

Where Lungscreen is headquartered

Location

Headquarters

HQ city
Buderim
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Lungscreen business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Government-Commissioned Screening Services: Lungscreen is the sole appointed provider by the Queensland Government to deliver dual-read ILO screening under the Coal Mine Workers' Health Scheme. Revenue is derived from legislated health assessments that coal and quarry mine workers are required to undergo at least every 5 years, before employment, and at retirement.
  2. Fee-for-Service Occupational Lung Disease Screening: Chest X-ray ILO reporting, spirometry coordination, and dual-reading services are billed per worker per assessment. Pricing schedules are publicly available (Schedule of Fees). Services cover coal mine workers, mineral mine, and quarry workers under Queensland regulations.
  3. National Lung Cancer Screening Program (NLCSP) Services: Lung cancer screening services including LDCT scans, AI-driven reporting, synoptic report generation, and Telstra Health registry integration, provided to radiology providers and GP practices participating in the national program.
  4. Lung Nodule Management Services: Virtual Lung Nodule Clinic providing specialist clinical review, coordinated follow-up, and surveillance services for incidental pulmonary nodules across Australia, supporting both patients and referring clinicians.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractOccupational Lung Disease Screening - Per Worker Assessment

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Lungscreen product offering

Product offering

Core offering

Lungscreen delivers lung screening and diagnostic imaging services covering occupational lung disease screening for mine and quarry workers, low-dose CT lung cancer screening under the National Lung Cancer Screening Program (NLCSP), and virtual lung nodule management. The company operates a proprietary cloud-based reporting platform (Radar), a Vendor Neutral Archive (VNA) on Australian-hosted Microsoft Azure, and AI-driven image analysis, with dual-read ILO-standard reporting performed by NIOSH-accredited B-Reader radiologists.

Product overview

Lungscreen is a lung screening technology platform consisting of three core service areas: Occupational Lung Disease Screening (covering Coal Mine Workers' Health Scheme and Mining & Quarrying programs), Lung Cancer Screening (National Lung Cancer Screening Program), and Lung Nodule Management. The platform is powered by two proprietary technology systems: Radar, a cloud-based reporting software for radiologists with double-reporting and adjudication workflows, and a Vendor Neutral Archive (VNA) for secure image storage. AI capabilities augment nodule detection, characterisation, and report generation across all screening services.

Differentiator

Problem solved

Functional benefit

Brands

  • Radar: Bespoke cloud-based reporting software for radiologists, designed to streamline and standardise the reporting process for occupational health.
  • VNA (Vendor Neutral Archive)

Quantifiable outcome

  • Lungscreen is the only organisation appointed by the Queensland Government to deliver dual-read ILO screening under the Coal Mine Workers' Health Scheme
  • +3 more outcomes

Companies that use Lungscreen

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles5 records

Lungscreen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature7 records

Lungscreen partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • University of Illinois at Chicago (UIC)coreStrategic or Co-development PartnerLungscreen participates in an international auditing program with UIC, a recognised authority in ILO reporting. This benchmarking partnership ensures Lungscreen's processes and radiologist reporting meet global best practices and maintains high standards of diagnostic accuracy in lung health.
  • Telstra HealthcoreTechnology or IntegrationLungscreen's reporting platform is integrated with Telstra Health for the National Lung Cancer Screening Program, enabling automated submission of structured, synoptic reports with detailed nodule data, Lung-RADS scores, patient demographics, and smoking history to the national registry.
  • Lumus ImagingcoreChannel Partner/ Reseller/ DistributorLumus Imaging is a radiology provider partner that uses Lungscreen's AI-enabled lung cancer screening platform and compliant synoptic reporting infrastructure. Their clinics perform CT scans and leverage Lungscreen's integrated reporting platform.
  • PRP ImagingcoreChannel Partner/ Reseller/ DistributorPRP Imaging is a radiology provider partner using Lungscreen's reporting platform and nodule management services for lung screening and occupational lung disease assessments.
  • Carlisle HealthminorChannel Partner/ Reseller/ DistributorCarlisle Health is a radiology provider partner for lung cancer screening and occupational lung disease services using Lungscreen's platform.
  • Radiology SAminorChannel Partner/ Reseller/ DistributorRadiology SA is a radiology provider partner using Lungscreen's platform for lung screening services.
  • Imaging AssociatesminorChannel Partner/ Reseller/ DistributorImaging Associates is a radiology provider partner for lung cancer screening program services using Lungscreen's platform.
  • Resources Safety and Health Queensland (RSHQ)coreChannel Partner/ Reseller/ DistributorRSHQ is a Queensland government body regulating mining safety. Lungscreen is the sole appointed provider of dual-read ILO screening services under the Coal Mine Workers' Health Scheme, a legislated program protecting respiratory health of workers in Queensland's coal mining industry.
  • Microsoft AzurecoreTechnology or IntegrationLungscreen's VNA is hosted on Microsoft Azure servers located in Australia. Azure is endorsed by the Australian Federal Government due to its security protocols, ensuring all patient data is secure in line with Australia's privacy policies.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Lungscreen competitors and assessment

Company assessment

Broad incumbents

  • Sonic HealthPlus: Australia's largest occupational health provider delivering pre-employment and periodic health assessments across industries including mining. Comparable to Lungscreen as an occupational screening provider to Queensland mining workers, with similar employer-led channels and health assessment workflow orientation.
  • Capitol Health: ASX-listed Australian diagnostic imaging network providing radiology services across multiple states. Comparable to Lungscreen as a clinical imaging provider for lung cancer screening and adjacent diagnostic workflows, though diversified across all modalities rather than lung-specialised.
  • I-MED Radiology Network: Australia's largest radiology provider, operating hundreds of clinics across the country. Directly comparable to Lungscreen as a clinical imaging provider for lung cancer screening under NLCSP and adjacent occupational imaging, though it operates across all modalities rather than specialising in lung screening.
  • Lunit: Korean-listed medical imaging AI company with FDA-cleared lung nodule detection and breast cancer AI products (post-Volpara acquisition). Comparable in lung cancer and imaging AI modality, and increasingly relevant as NLCSP and similar screening programs worldwide standardise AI-augmented reporting workflows.
  • Aspen Medical: Australian-headquartered occupational and remote health services provider with established mining and industrial health screening offerings. Comparable to Lungscreen's occupational lung disease screening segment for mining and industrial workforces, particularly in Queensland and regional Australia.

Emerging players

  • Optellum: AI-driven lung cancer screening platform for pulmonary nodule management and Lung-RADS decision support. Comparable to Lungscreen's AI nodule detection and lung cancer screening capabilities, though Optellum is an AI software provider rather than a full-service screening operator.
  • Riverain Technologies: US-based AI imaging company specialising in chest X-ray and CT interpretation, including ClearRead and LungPlot products. Direct technology peer to Lungscreen in AI-driven nodule detection and chest X-ray reporting augmentation.
  • Annalise.ai: Australian-headquartered comprehensive radiology AI platform covering chest X-ray and CT findings, including lung-related pathologies. Direct technology overlap with Lungscreen's AI imaging and report-generation stack, and is an Australian-based peer competing for similar radiology-provider AI deployments.

Direct peers

  • Lumus Imaging: Australian radiology provider and named Lungscreen channel partner using its AI-enabled lung cancer screening platform. Operates many of the same chest X-ray and CT imaging clinics Lungscreen relies on for scanning delivery, making it both a partner and a potential in-house competitor for primary lung screening reporting.

Regional players

  • Queensland X-Ray: Major Queensland-headquartered diagnostic imaging provider operating across multiple modalities. Comparable to Lungscreen as a regional radiology network in Queensland with potential overlap in lung CT, NLCSP, and occupational chest imaging volumes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Lungscreen social profiles

Digital presence

Lungscreen compliance and trust

Trust signal

Compliance2 records

Lungscreen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lungscreen leadership team

Management profile

Number of profiles

Profiles11 records

Lungscreen funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lungscreen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lungscreen

What does Lungscreen do?

Lungscreen delivers lung screening and diagnostic imaging services covering occupational lung disease screening for mine and quarry workers, low-dose CT lung cancer screening under the National Lung Cancer Screening Program (NLCSP), and virtual lung nodule management. The company operates a proprietary cloud-based reporting platform (Radar), a Vendor Neutral Archive (VNA) on Australian-hosted Microsoft Azure, and AI-driven image analysis, with dual-read ILO-standard reporting performed by NIOSH-accredited B-Reader radiologists.

Is Lungscreen a public or private company?

Lungscreen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Lungscreen founded?

Lungscreen was founded in -1. It employs 1 to 10 people.

Where is Lungscreen based?

Lungscreen is headquartered in Buderim, Australia, in the Oceania region.

How does Lungscreen make money?

Four revenue lines are on record. Government-Commissioned Screening Services are the primary driver. The others are fee-for-Service Occupational Lung Disease Screening, national Lung Cancer Screening Program (NLCSP) Services and lung Nodule Management Services.

Who are Lungscreen's main competitors?

Broad incumbents on record are Sonic HealthPlus, Capitol Health, I-MED Radiology Network, Lunit and Aspen Medical. Emerging players are Optellum, Riverain Technologies and Annalise.ai. Lumus Imaging is listed as a direct peer. Queensland X-Ray is listed as a regional player.

Does Lungscreen have an API?

No public API is recorded for Lungscreen.

What industry is Lungscreen in?

Lungscreen's product category is Lung Screening Services. Its primary akta.pro industry code is HLAKANAI, Lung Cancer Screening & Pulmonary Nodule Clinic, with a secondary code of HLAKANAN, Occupational & Environmental Lung Disease Clinic. Its NAICS code is 621512 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales